BellaMia Technologies and Dominion Aesthetic Technologies Complete $200M Strategic Merger
May 20, 2026
BellaMia Technologies and Dominion Aesthetic Technologies completed a strategic merger valued at $200 million, combining their laser and robotic medical aesthetics technologies. The merged company will operate under the BellaMia Technologies name with Janet Campbell as CEO, aiming to expand commercial reach and accelerate product development across body contouring and skin rejuvenation.
- Buyers
- BellaMia Technologies, Inc.
- Targets
- Dominion Aesthetic Technologies, Inc., BellaMia Technologies, Inc.
- Industry
- Medical Devices
- Location
- Texas, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
NextEra Energy Acquires Dominion Energy in $66.8B All-Stock Merger
May 18, 2026
Utilities
NextEra Energy, Inc. has entered into a definitive, all-stock agreement to combine with Dominion Energy, Inc. in a transaction valued at approximately $66.8 billion. Dominion shareholders will receive 0.8138 shares of NextEra Energy per Dominion share plus a one-time $360 million cash payment, with the combined company expected to serve about 10 million utility customer accounts across Florida, Virginia, North Carolina and South Carolina.
-
MD Esthetics Joins With Glow Aesthetics Medical Spa to Accelerate New England Expansion
April 13, 2026
Healthcare Services
MD Esthetics, a multi-state medical aesthetics and wellness platform backed by New Harbor Capital, formed a strategic partnership with Glow Aesthetics Medical Spa. The deal is intended to preserve Glow’s brand while providing MD Esthetics’ strategic resources to support regional growth across New England.
-
AstraZeneca Acquires Modella AI
January 15, 2026
AI & Machine Learning
AstraZeneca has acquired Modella AI, a Boston-based biomedical AI company, to integrate its multimodal foundation models and agentic AI platform into AstraZeneca's global oncology R&D organization. The deal expands an existing multi-year collaboration to accelerate clinical development, improve biomarker discovery, and drive data-driven decision-making across AstraZeneca's oncology pipeline; financial terms were not disclosed.
-
CurrentBody Acquires Tria Beauty
October 21, 2024
Consumer Products
CurrentBody has completed the acquisition of Tria Beauty, the pioneer in at‑home laser hair removal and skin rejuvenation devices. The purchase brings Tria into CurrentBody's Beauty Tech portfolio alongside CurrentBody Skin and ZIIP, expanding CurrentBody's capabilities in clinical-grade at‑home beauty technology.
-
Bimini Health Tech Subsidiary Acquires Ideal Implant, Inc. Assets
August 17, 2023
Medical Devices
A newly formed subsidiary of Bimini Health Tech acquired substantially all assets of Ideal Implant, Inc., including intellectual property, regulatory approvals (FDA Class III for the breast implant), inventory and certain manufacturing capacity. The acquisition adds the Serene Breast Implant to Bimini’s plastic and reconstructive surgery portfolio and is intended to reposition the technology for the hospital setting to drive growth.
-
Crown Laboratories Acquires Eclipse Medcorp's Aesthetics Assets
May 24, 2022
Medical Devices
Crown Laboratories has acquired the global, aesthetics-focused assets of Eclipse Medcorp, LLC, expanding Crown's aesthetics product portfolio and integrating Eclipse's devices into its Aesthetics business unit. The deal aims to broaden Crown's product offerings to aesthetics providers domestically and internationally and preserve service and medical-education support for Eclipse customers under Crown.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.